[1]
|
Pregnancy-associated breast cancer: does timing of presentation affect outcome?
Breast Cancer Research and Treatment,
2023
DOI:10.1007/s10549-022-06833-8
|
|
|
[2]
|
Pregnancy-associated breast cancer: does timing of presentation affect outcome?
Breast Cancer Research and Treatment,
2023
DOI:10.1007/s10549-022-06833-8
|
|
|
[3]
|
Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?
Critical Reviews in Oncology/Hematology,
2022
DOI:10.1016/j.critrevonc.2022.103824
|
|
|
[4]
|
Outcomes after treatment of breast cancer during pregnancy including taxanes and/or granulocyte colony-stimulating factor use: findings from a multi-institutional retrospective analysis
Breast Cancer Research and Treatment,
2022
DOI:10.1007/s10549-022-06621-4
|
|
|
[5]
|
Direct and indirect effects on child neurocognitive development when maternal cancer is diagnosed during pregnancy: What do we know so far?
Critical Reviews in Oncology/Hematology,
2022
DOI:10.1016/j.critrevonc.2022.103824
|
|
|
[6]
|
Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy
Cancers,
2021
DOI:10.3390/cancers13061214
|
|
|
[7]
|
Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial
BMC Cancer,
2021
DOI:10.1186/s12885-021-08197-6
|
|
|
[8]
|
Management of pregnancy in women with cancer
International Journal of Gynecologic Cancer,
2021
DOI:10.1136/ijgc-2020-001776
|
|
|
[9]
|
Supportive medication in cancer during pregnancy
BMC Pregnancy and Childbirth,
2020
DOI:10.1186/s12884-020-03432-7
|
|
|
[10]
|
In Vitro Fertilization
2019
DOI:10.1007/978-3-319-43011-9_62
|
|
|
[11]
|
Contemporary management of breast cancer during pregnancy and subsequent lactation in a multicenter cohort of young women with breast cancer
The Breast Journal,
2019
DOI:10.1111/tbj.13431
|
|
|
[12]
|
A Review of Pregnancy-Associated Breast Cancer: Diagnosis, Local and Systemic Treatment, and Prognosis
Journal of Women's Health,
2018
DOI:10.1089/jwh.2018.7264
|
|
|
[13]
|
Cancer in pregnancy
Current Opinion in Oncology,
2017
DOI:10.1097/CCO.0000000000000386
|
|
|
[14]
|
Breast Cancer
2017
DOI:10.1007/978-3-319-48848-6_59
|
|
|
[15]
|
Treatment of Breast Cancer During Pregnancy
Current Breast Cancer Reports,
2017
DOI:10.1007/s12609-017-0256-5
|
|
|
[16]
|
Multidisciplinary Management of Breast Cancer During Pregnancy
The Oncologist,
2017
DOI:10.1634/theoncologist.2016-0208
|
|
|
[17]
|
Cancer in pregnancy: safety and efficacy of systemic therapies
Current Opinion in Oncology,
2017
DOI:10.1097/CCO.0000000000000386
|
|
|
[18]
|
Cancer and Fertility
Current Clinical Urology,
2016
DOI:10.1007/978-3-319-27711-0_12
|
|
|
[19]
|
Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions
Journal of Reproductive Immunology,
2015
DOI:10.1016/j.jri.2015.01.010
|
|
|
[20]
|
Maternal and Neonatal Outcomes of Dose-Dense Chemotherapy for Breast Cancer in Pregnancy
Obstetrics & Gynecology,
2012
DOI:10.1097/AOG.0b013e31826c32d9
|
|
|